ICYMI - One-off bowel scope cuts cancer risk for at least 17 years
Friday, 10 March 2017 12:45
In case you missed it, on 21 February 2017 The Lancet published an article by BSG member Prof Wendy Atkin and colleagues. The subject was the outcome of an RCT funded by the NIHR EME programme and CRUK. The trial, with more than 170,000 participants, investigated the effect of a single flexible sigmoidoscopy (FS) on colorectal cancer incidence and mortality after 17 years of follow-up. The study showed that a one-off FS continues to provide significant levels of protection from colorectal cancer diagnosis and death, with protection lasting at least 17 years. The NIHR announced the findings in their own press release. Further background to the trial is available on Prof Atkins' website.